Association between triglyceride-glucose index and cardiovascular disease in US adults with chronic kidney disease: a population-based study DOI Creative Commons
Lijia Liu, Hui–Chuan Sun,

Lan Yi

и другие.

BMC Cardiovascular Disorders, Год журнала: 2024, Номер 24(1)

Опубликована: Дек. 20, 2024

Triglyceride-glucose (TyG) index, which is a valuable measure of insulin resistance, has been found to have predictive value for cardiovascular disease (CVD). However, its relationship with CVD among individuals chronic kidney (CKD) not thoroughly investigated. This study focused on examining the TyG index and CKD patients in United States. 3507 eligible participants from National Health Nutrition Examination Survey (2003–2018) were surveyed this study. Methods such as multivariable logistic regression analysis smooth curve fitting employed estimate how linked populations. Subgroup interaction analyses conducted order figure out potential moderating effects various factors. In cross-sectional based population CKD, 29.5% also had CVD. An independent positive link was revealed (OR 1.213, 95% CI 1.059, 1.389). association nonlinear, threshold effect observed at 8.98. The results subgroup suggested that relationships differed according stage: 1.048, 0.857, 1.282) stages 1–2; 1.267, 1.030–1.560) stage 3; 2.131, 1.224–3.709) 4–5. Interaction further stage. Additionally, specific types, only coronary heart (CHD) significant 1.617, 1.123, 2.327). identified be independently positively related likelihood CVD, specifically populations an eGFR < 60 mL/min/1.73 m². effect. highlight tool screening risk assessment suffering warranting investigation.

Язык: Английский

Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging DOI

Anna De Bartolo,

Tommaso Angelone, Carmine Rocca

и другие.

Vascular Pharmacology, Год журнала: 2025, Номер unknown, С. 107462 - 107462

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

1

Global, regional, and national burden of heart failure and its underlying causes, 1990–2021: results from the global burden of disease study 2021 DOI Creative Commons

Jun Ran,

Ping Zhou, Jinxi Wang

и другие.

Biomarker Research, Год журнала: 2025, Номер 13(1)

Опубликована: Янв. 23, 2025

Abstract Background Heart failure (HF) remains a significant public health challenge globally. This study aims to systematically analyze the global HF disease burden from 1990 2021 across temporal, spatial, and demographic dimensions provide evidence for targeted prevention control strategies. Methods Using data Global Burden of Disease (GBD) study, we analyzed through prevalent cases, years lived with disability (YLDs), age-standardized rates per 100,000 population. Temporal trends were evaluated using estimated annual percentage change (EAPC) joinpoint regression analysis. The relationship between Socio-demographic Index (SDI) was explored Pearson correlation analysis, while attribution analysis identified main causes HF. When appropriate, analyses stratified by 5 SDI regions, 21 GBD 204 countries territories, 20 age groups, both sexes. Results prevalence YLDs showed substantial increases 2021, increasing 641.14 676.68 Notably, high-SDI regions exhibited declining since 2019, indicating potential turning point. High-income North America bears heaviest South Asia shows fastest growth rate. level negligible. in males consistently exceeded that females, rising sharply after 60. their attributable proportions were: ischemic heart (34.53%), hypertensive (22.53%), other cardiomyopathies (7.61%), chronic obstructive pulmonary (6.51%), congenital anomalies (5.69%), distribution patterns differing groups regions. Conclusion increased significantly over recent decades, point 2019 marked regional disparities. It is essential prioritize heavy burdens or rapid rates, strengthen management major causes, monitor post-COVID era.

Язык: Английский

Процитировано

0

IL-11 promotes Ang II-induced autophagy inhibition and mitochondrial dysfunction in atrial fibroblasts DOI Creative Commons
Jun Wang, Qianyu Zhang,

Yunjie Han

и другие.

Open Life Sciences, Год журнала: 2025, Номер 20(1)

Опубликована: Янв. 1, 2025

Abstract This study aimed to investigate potential targets for the pathogenesis of atrial fibrillation facilitate development effective treatments. Atrial fibroblasts were isolated and stimulated with 1 μM angiotensin-II (Ang-II) 24 h. To increase interleukin 11 (IL-11) expression, overexpression plasmids transfected into fibroblasts. The role underlying mechanism IL-11 in examined by immunofluorescence, measurements reactive oxygen species (ROS) mitochondrial membrane (MMP), western blotting assays. Results demonstrated that was upregulated Ang-II-elicited Ang-II treatment increases alpha-smooth muscle actin (α-SMA), ROS MMP levels, p62 expression but decreases microtubule-associated protein light chain 3 II/I (LC3 II/I) Beclin-1 expressions These effects further amplified overexpression. Mechanistically, mammalian target rapamycin (mTOR) pathway enhanced Ang-II-induced fibroblasts, which elevated upregulation. facilitates Ang II-induced differentiation myofibroblasts promoting oxidative stress, dysfunction, autophagy inhibition through mTOR pathway.

Язык: Английский

Процитировано

0

Epigenetic mechanisms underlying the beneficial effects of cardiac rehabilitation. An overview from the working groups of “cellular and molecular biology of the heart” and “cardiac rehabilitation and cardiovascular prevention” of the Italian Society of Cardiology (SIC) DOI Creative Commons
Valeria Visco, Maurizio Forte, Francesco Giallauria

и другие.

International Journal of Cardiology, Год журнала: 2025, Номер unknown, С. 133166 - 133166

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Development and validation of an integrated prognostic model for all-cause mortality in heart failure: a comprehensive analysis combining clinical, electrocardiographic, and echocardiographic parameters DOI Creative Commons
Yahui Li, Jiayu Xu, Xuhui Liu

и другие.

BMC Cardiovascular Disorders, Год журнала: 2025, Номер 25(1)

Опубликована: Март 26, 2025

Accurate risk prediction in heart failure remains challenging due to its complex pathophysiology. We aimed develop and validate a comprehensive prognostic model integrating demographic, electrocardiographic, echocardiographic, biochemical parameters. conducted retrospective cohort study of 445 patients. The was randomly divided into training (n = 312) validation 133) sets. Feature selection performed using LASSO regression followed by backward stepwise Cox regression. A nomogram constructed based on independent predictors. Model performance assessed through discrimination, calibration, decision curve analyses. Random survival forest analysis variable importance. During median follow-up 4.14 years, 142 deaths (31.91%) occurred. Our development systematic approach: initial feature identified 15 potential predictors, which were further refined nine predictors final included age, NYHA class, left ventricular systolic dysfunction, atrial septal defect, aortic valve annulus calcification, tricuspid regurgitation severity, QRS duration, T wave offset, NT-proBNP. integrated demonstrated good discrimination for 2-, 3-, 5-year mortality both (AUCs: 0.726, 0.755, 0.809) cohorts 0.686, 0.678, 0.706). Calibration plots analyses confirmed the model's reliability clinical utility across different time horizons. individualized prediction. Kaplan-Meier individual revealed significant stratification outcomes, while restricted cubic spline non-linear relationships between continuous variables risk. top five (age, NT-proBNP, NYHA), compared with our nine-variable model, confirming superior all points. showed robust predicting all-cause ability provide estimates may facilitate decision-making patient stratification. Not applicable.

Язык: Английский

Процитировано

0

Mitigating Diabetic Cardiomyopathy: The Synergistic Potential of Sea Buckthorn and Metformin Explored via Bioinformatics and Chemoinformatics DOI Creative Commons
Kamran Safavi, Navid Abedpoor, Fatemeh Hajibabaie

и другие.

Biology, Год журнала: 2025, Номер 14(4), С. 361 - 361

Опубликована: Март 31, 2025

Diabetic cardiomyopathy (DCM), a critical complication of type 2 diabetes mellitus (T2DM), is marked by metabolic dysfunction, oxidative stress, and chronic inflammation, ultimately progressing to heart failure. This study investigated the synergistic therapeutic potential Hippophae rhamnoides L. (sea buckthorn, SBU) extract metformin in mouse model T2DM-induced DCM. T2DM was induced using 45% high-fat-AGEs-enriched diet, followed treatment with SBU, metformin, or their combination. Treatment effects were monitored through bioinformatic analysis, chemoinformatic prediction, behavioral testing, biochemical assays, histopathological evaluations gene expression profiles. Based on we identified key hub genes involved diabetic including SERPINE1, NRG1, MYH11, PTH, NR4A2, NRF2, PGC1α, GPX4, ATF1, ASCL2, NOX1, NLRP3, CCK8, COX2, CCL2, PTGS2, EGFR, oncostatin, which are pivotal modulating ferroptosis pathway. Furthermore, long non-coding RNAs (lncRNAs) NEAT1 MALAT1, regulators inflammation cell death, effectively downregulated, correlating decreased levels pro-inflammatory marker oncostatin. The combined therapy significantly improved glucose regulation, reduced systemic protected from damage. Histopathological analysis revealed notable reductions cardiac necrosis fibrosis. Particularly, combination SBU demonstrated effect, surpassing benefits individual treatments preventing These findings highlight integrating as novel strategy for managing DCM targeting both ferroptosis-related pathways. dual intervention opens promising avenues future clinical applications disease management, offering comprehensive approach mitigating progression

Язык: Английский

Процитировано

0

A machine learning tool for identifying newly diagnosed heart failure in individuals with known diabetes in primary care DOI Creative Commons
Per Wändell, Axel C. Carlsson,

Julia Eriksson

и другие.

ESC Heart Failure, Год журнала: 2024, Номер unknown

Опубликована: Окт. 20, 2024

Abstract Aims We aimed to create a predictive model utilizing machine learning (ML) identify new cases of congestive heart failure (CHF) in individuals with diabetes primary health care (PHC) through the analysis diagnostic data. Methods used sex‐ and age‐matched case–control design. Cases CHF were identified across all outpatient settings 2015–2022 ( n = 9098). included 30 years above, by sex age groups 30–65 >65 years. The controls (five per case) sampled from without at any time between 2010 2022, total 45 490. From stochastic gradient boosting (SGB) technique model, we obtained rank 10 most important factors related newly diagnosed diabetes, normalized relative influence (NRI) score corresponding odds ratio marginal effects (OR ME ). Area under curve (AUC) was calculated. Results For women years, 488 3240 CHF, respectively, men 1196 4174 cases. Among four (divided lower higher age) for found number visits 12 months before diagnosis (NRI 44.3%–55.9%), coronary artery disease 2.9%–7.8%), atrial fibrillation flutter 6.6%–12.2%) ‘abnormalities breathing’ (ICD‐10 code R06) 2.6%–4.4%) groups. younger women, COPD 2.7%) contributed effect, while older oedema 3.1%) 3.5%) effect. both groups, chronic renal had effect 3.9%–5.1%) prediction among patients high, AUC around 0.85 sensitivity over 0.783 specificity 0.708 Conclusions An SGB using routinely collected data about diagnoses care, can accurately predict risk diabetes. Age difference warrant further examination.

Язык: Английский

Процитировано

1

Senolytics rejuvenate aging cardiomyopathy in human cardiac organoids DOI Creative Commons
Mariangela Scalise, Eleonora Cianflone,

Claudia Quercia

и другие.

Mechanisms of Ageing and Development, Год журнала: 2024, Номер unknown, С. 112007 - 112007

Опубликована: Ноя. 1, 2024

Язык: Английский

Процитировано

1

Association between triglyceride-glucose index and cardiovascular disease in US adults with chronic kidney disease: a population-based study DOI Creative Commons
Lijia Liu, Hui–Chuan Sun,

Lan Yi

и другие.

BMC Cardiovascular Disorders, Год журнала: 2024, Номер 24(1)

Опубликована: Дек. 20, 2024

Triglyceride-glucose (TyG) index, which is a valuable measure of insulin resistance, has been found to have predictive value for cardiovascular disease (CVD). However, its relationship with CVD among individuals chronic kidney (CKD) not thoroughly investigated. This study focused on examining the TyG index and CKD patients in United States. 3507 eligible participants from National Health Nutrition Examination Survey (2003–2018) were surveyed this study. Methods such as multivariable logistic regression analysis smooth curve fitting employed estimate how linked populations. Subgroup interaction analyses conducted order figure out potential moderating effects various factors. In cross-sectional based population CKD, 29.5% also had CVD. An independent positive link was revealed (OR 1.213, 95% CI 1.059, 1.389). association nonlinear, threshold effect observed at 8.98. The results subgroup suggested that relationships differed according stage: 1.048, 0.857, 1.282) stages 1–2; 1.267, 1.030–1.560) stage 3; 2.131, 1.224–3.709) 4–5. Interaction further stage. Additionally, specific types, only coronary heart (CHD) significant 1.617, 1.123, 2.327). identified be independently positively related likelihood CVD, specifically populations an eGFR < 60 mL/min/1.73 m². effect. highlight tool screening risk assessment suffering warranting investigation.

Язык: Английский

Процитировано

0